News on MetaClin Research%2C Inc. from BioPortfolio.com http://www.BioPortfolio.com Consolidated MetaClin Research%2C Inc. news from BioPortfolio.com Wed, 10 Feb 2010 12:36:15 GMT en Goodwin Biotechnology Inc. and Macrocyclics Announce Collaborationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041466&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041466&THISHREF=http://c.moreover.com/click/here.pl%3fz2539128755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041466&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041466&THISHREF=http://c.moreover.com/click/here.pl%3fz2539128755%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYour Story: Life Sciences: Study results from Ajinomoto Co., Inc. broaden understanding of life scienceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039750&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039750&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357808%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039750&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039750&THISHREF=http://c.moreover.com/click/here.pl%3fz2538357808%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Visualase To Be Awarded $2.1 Million For Prostate Cancer Research.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040381&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040381&THISHREF=http://c.moreover.com/click/here.pl%3fz2538715084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040381&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040381&THISHREF=http://c.moreover.com/click/here.pl%3fz2538715084%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Visualase To Be Awarded $2.1 Million For Prostate Cancer Research.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040376&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040376&THISHREF=http://c.moreover.com/click/here.pl%3fz2538712920%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040376&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040376&THISHREF=http://c.moreover.com/click/here.pl%3fz2538712920%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Visualase To Be Awarded $2.1 Million For Prostate Cancer Researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040290&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040290&THISHREF=http://c.moreover.com/click/here.pl%3fz2538692280%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040290&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040290&THISHREF=http://c.moreover.com/click/here.pl%3fz2538692280%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPRWeb: Bend Research a key player in state biotech | February 8, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038598&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038598&THISHREF=http://c.moreover.com/click/here.pl%3fz2537670985%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038598&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038598&THISHREF=http://c.moreover.com/click/here.pl%3fz2537670985%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBend Bulletin: Enzyme Research: Research conducted at Pfizer Inc. has provided new information about enzyme researchhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033257&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033257&THISHREF=http://c.moreover.com/click/here.pl%3fz2535088530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033257&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033257&THISHREF=http://c.moreover.com/click/here.pl%3fz2535088530%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Bend Research a key player in state biotechhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032957&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032957&THISHREF=http://c.moreover.com/click/here.pl%3fz2534920063%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032957&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032957&THISHREF=http://c.moreover.com/click/here.pl%3fz2534920063%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBend Bulletin: Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call for Friday, February 12, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037847&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037847&THISHREF=http://c.moreover.com/click/here.pl%3fz2537331055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037847&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037847&THISHREF=http://c.moreover.com/click/here.pl%3fz2537331055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call for Friday, February 12, 2010 / CORPORATE NAME OFFICIALLY CHANGED TO PACIFIC BIOMARKERS, INC. FROM PACIFIC BIOMETRICS, INC.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034988&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034988&THISHREF=http://c.moreover.com/click/here.pl%3fz2536076839%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034988&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034988&THISHREF=http://c.moreover.com/click/here.pl%3fz2536076839%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Liberty Analytics Co. Initiates Independent Research Coverage on NexMed, Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036684&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036684&THISHREF=http://c.moreover.com/click/here.pl%3fz2536703472%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036684&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036684&THISHREF=http://c.moreover.com/click/here.pl%3fz2536703472%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInterest!ALERT: Pharmacokinetics: Research conducted at Avigen, Inc. has provided new information about pharmacokineticshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033259&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033259&THISHREF=http://c.moreover.com/click/here.pl%3fz2535088698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033259&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033259&THISHREF=http://c.moreover.com/click/here.pl%3fz2535088698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: ComScore: Apple gains US smart phone sharehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032353&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032353&THISHREF=http://c.moreover.com/click/here.pl%3fz2534620123%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032353&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032353&THISHREF=http://c.moreover.com/click/here.pl%3fz2534620123%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: ARCA biopharma, Inc. (formerly ARCA Discovery, Inc.)-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036856&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036856&THISHREF=http://c.moreover.com/click/here.pl%3fz2536793458%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036856&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036856&THISHREF=http://c.moreover.com/click/here.pl%3fz2536793458%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: AVEO Pharmaceuticals, Inc. (formerly GenPath Pharmaceuticals, Inc.)-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036074&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036074&THISHREF=http://c.moreover.com/click/here.pl%3fz2536486457%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036074&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=MetaClin%20Research,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036074&THISHREF=http://c.moreover.com/click/here.pl%3fz2536486457%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: